Search filters

List of works by Atsuko Ikenouchi-Sugita

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine

scientific article published in 2021

A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report

scientific article published in 2021

A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF).

scientific article published in January 2009

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder

scientific article published in January 2009

A close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers

scientific article

Abnormal white matter integrity in the corpus callosum among smokers: tract-based spatial statistics

scientific article

Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study

scientific article

Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression

scientific article published on 11 December 2009

Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline

scientific article

Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia ⬇️

scientific article published on December 27, 2012

Anti-Müllerian hormone as a marker of ovarian reserve in patients with ovarian malignancies who have undergone fertility-preserving surgery and chemotherapy ⬇️

scientific article published on January 10, 2013

Anti-Müllerian hormone as a possible predictor of fecundability in subfertile women over 38 years: a retrospective cohort study

scientific article published on 17 July 2014

Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients

scientific article

Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study

scientific article published in March 2010

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study

scientific article published on 29 October 2020

Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia

scientific article published in December 2009

Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder

scientific article published on January 2010

Blood levels of catecholamine metabolites and brain-derived neurotrophic factor in a case of Sydenham's chorea

scientific article published in January 2009

Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study

scientific article published on 16 December 2020

Brain-derived neurotrophic factor (BDNF) and mood disorder

scientific article published on November 2010

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study

scientific article

Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder

scientific article

Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder

scientific article published on 17 July 2012

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes

scientific article published on December 2008

Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study

scientific article published on 12 March 2010

Current smoking rate in patients with psychiatric disorders in Japan: questionnaire survey

scientific article published on 17 April 2013

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients

scientific article published in March 2010

Does subjective sleep quality improve by a walking intervention? A real-world study in a Japanese workplace

scientific article published on 24 October 2016

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder

scientific article published on 24 April 2014

Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders

scientific article published in October 2006

Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients

scientific article published on 01 October 2007

Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine

scientific article published on 5 August 2009

Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients

scientific article published in January 2007

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients

scientific article

Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression

scientific article published on 05 December 2020

Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study

scientific article

Erythema Annulare Centrifugum Associated with Herpes Zoster ⬇️

scientific article published on September 1, 2012

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review

scientific article published on 24 April 2013

Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers

scientific article published in January 2009

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression

scientific article published on 28 March 2009

Inducible nitric oxide synthase downmodulates contact hypersensitivity by suppressing dendritic cell migration and survival

scientific article published on 03 September 2009

Niacin deficiency and cutaneous immunity

scientific article published on January 2015

No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients

scientific article published on 30 April 2012

No alterations of brain GABA after 6months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia ⬇️

scientific article published on August 19, 2010

No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients ⬇️

scientific article published on June 16, 2011

No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations ⬇️

scientific article published on August 1, 2010

No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia.

scientific article

Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels

scientific article published in February 2010

One-year follow-up of serum antimüllerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve?

scientific article

Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex

scientific article published on 6 November 2009

Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine

scientific article published on 02 November 2020

Plasma Levels of Metabolites of Catecholamine in Nicotine-Dependent Patients Treated With Varenicline ⬇️

scientific article published on October 17, 2011

Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus

scientific article published in March 2013

Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report

scientific article

Plasma levels of brain‐derived neurotrophic factor and interleukin‐6 in patients with dysthymic disorder: comparison with age‐ and sex‐matched major depressed patients and healthy controls ⬇️

scientific article published on November 1, 2010

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder

scientific article published on 30 June 2013

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism

scientific article published on 13 October 2009

Prostaglandin E₂ is critical for the development of niacin-deficiency-induced photosensitivity via ROS production

scientific article published on 17 October 2013

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.

scientific article published in August 2009

Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.

scientific article

Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan ⬇️

scientific article published on September 15, 2010

Reliability, validity and clinical utility of a Japanese version of the Social Adaptation Self‐evaluation Scale as calibrated using the Beck Depression Inventory ⬇️

scientific article published on December 1, 2011

Serum Brain–Derived Neurotrophic Factor Levels at 6 Months After Remission Are Not Associated With Subsequent Depressive Episodes ⬇️

scientific article published on February 1, 2013

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs.

scientific article published on 21 January 2014

Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus

scientific article published in March 2010

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD) ⬇️

scientific article published on August 10, 2012

Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.

scientific article published in July 2009

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.

scientific article

Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients ⬇️

scientific article published on 05 December 2011

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia ⬇️

scientific article published on April 3, 2012

Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?

scientific article published on 17 November 2007

Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder

scientific article published on 25 April 2020

Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients

scientific article

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients

scientific article published on 19 February 2011

The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients ⬇️

scientific article published on March 29, 2012

The effects of a walking intervention on depressive feelings and social adaptation in healthy workers.

scientific article published in March 2013

Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa

scientific article published on 01 August 2007

Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report

scientific article published in October 2011

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients

scientific article

Trichotilliomania responding to low-dose fluvoxamine

scientific article published in October 2009

Two cases of burning mouth syndrome treated with olanzapine

scientific article published in June 2008

Varenicline does not increase serum BDNF levels in patients with nicotine dependence

scientific article published in April 2010

[Review of pharmacological efficacies and side effects of antidepressants]

scientific article published on 01 September 2007

Paulina is supported by:

About Paulina

Help